Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gynecological Laparoscopic Surgery × Sufentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Pain 3 Carcinoma, Hepatocellular 3 Pain, Postoperative 2 Lung Neoplasms 2 Inflammation 2 Stomach Neoplasms 1 Postoperative Nausea and Vomiting 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Melanoma 1 Gynecological Laparoscopic Surgery 1 Emergence Delirium 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Sufentanil 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07372209 2026-01-28

Effects and Safety of Oliceridine in Anesthesia Induction:A Randomised Controlled Trial

Tangshan Maternal and Child Health Hospital

Phase NA Completed

Gynecological Laparoscopic Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡